Sandoz CEO Richard Saynor warned U.S. patients could ultimately bear the cost of threatened tariffs on imported generic drugs. Saynor said manufacturers facing steep tariffs could be forced to raise ...
As demand for GLP-1 based weight loss drugs explodes worldwide, and patents expire in some countries, generic manufacturers are stepping up production to gain a slice of the market. We look at what’s ...
“Globally, generics is consolidating,” chief executive Rajeev Nannapaneni told Mint, pointing out that most Western companies have exited the commodity generics space, leaving Indian drugmakers to ...
The UAE’s drive to become a regional pharmaceutical manufacturing hub is moving beyond traditional medicines, with local producers investing in complex generics and biosimilars as the country seeks ...
Aurobindo Pharma தனது துணை நிறுவனமான Lannett Company மூலம் அமெரிக்காவில் Advair Diskus ...
அமெரிக்க சந்தையில் தனது முதல் 'Inhalation' மருந்தை Aurobindo Pharma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results